story of the week
Diabetes Remission and Relapse Following an Intensive Metabolic Intervention Combining Insulin Glargine/Lixisenatide, Metformin, and Lifestyle Approaches
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial
Diabetes Obes Metab 2023 Aug 14;[EPub Ahead of Print], N McInnes, S Hall, HA Lochnan, SB Harris, Z Punthakee, RJ Sigal, I Hramiak, M Azharuddin, JF Liutkus, JF Yale, F Sultan, A Smith, RE Otto, D Sherifali, YY Liu, HC GersteinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.